Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-26 @ 2:40 PM
NCT ID:
NCT02901106
Eligibility Criteria:
Inclusion Criteria:
* patient 18 years old and more
* with multiple sclerosis according to the criteria of Mac Donald 2010 : relapsing-remitting (RR), secondary-progressive (SP) or primary-progressive (PP)
* for which treatment with dimethyl-fumarate has been prescribed
* followed at the Rothschild Foundation in the Neurology Department
* having given written consent to participation in the study
Exclusion Criteria:
* pregnant or breastfeeding woman
* patient with a measure of legal protection
* subject unaffiliated insurance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02901106
Study Brief:
Protocol Section:
NCT02901106